SFRP1 and cancer: SFRP1‐dependent inhibition of the Wnt/β‐catenin pathway has been expounded to hinder the tumorigenesis and tumor metastasis in several cancers such as epithelial ovarian cancer34 and nasopharyngeal carcinoma.35